BrainCells and Organon to collaborate in discovery and development of CNS drugs
News | 10. 23. 2006
BrainCells Inc. (BCI) and Organon, the human health care business unit of Akzo Nobel (Nasdaq: AKZOY), today announced they will collaborate in the discovery and development of drugs for the treatment of central nervous system (CNS) disorders.